These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4913377)

  • 1. Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species.
    Sandhu DK; Sandhu RS; Damodaran VN; Randhawa HS
    Sabouraudia; 1970 May; 8(1):32-8. PubMed ID: 4913377
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental aspergillosis in mice. II. Enhanced susceptibility of the cortisone treated mice to infection with Aspergillus fumigatus, Aspergillus flavus und Aspergillus niger.
    Bhatia VN; Mohapatra LN
    Mykosen; 1970 Feb; 13(2):105-10. PubMed ID: 5475238
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice.
    Merkow L; Pardo M; Epstein SM; Verney E; Sidransky H
    Science; 1968 Apr; 160(3823):79-81. PubMed ID: 5642312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphology of bronchopulmonary aspergillosis in roe deer and hares].
    Vítovec J; Vladík P; Proks C; Fragner P
    Vet Med (Praha); 1974; 19(2):127-33. PubMed ID: 4210141
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of experimental pulmonary aspergillosis in normal and cortisone-treated rats.
    Turner KJ; Hackshaw R; Papadimitriou J; Perrott J
    J Pathol; 1976 Feb; 118(2):65-73. PubMed ID: 1255306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillosis and lung defenses.
    Elstad MR
    Semin Respir Infect; 1991 Mar; 6(1):27-36. PubMed ID: 1887164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo.
    Merkow LP; Epstein SM; Sidransky H; Verney E; Pardo M
    Am J Pathol; 1971 Jan; 62(1):57-74. PubMed ID: 5538719
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental aspergillosis in rats infected via intraperitoneal and subcutaneous routes.
    Turner KJ; Hackshaw R; Papadimitriou J; Wetherall JD; Perrott J
    Immunology; 1975 Jul; 29(1):55-66. PubMed ID: 1095475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary aspergillosis: morphological study of 15 autopsy cases].
    Oddo D; González S
    Rev Med Chil; 1984 Mar; 112(3):247-51. PubMed ID: 6473966
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the pathogenesis of experimental pulmonary aspergillosis.
    Epstein SM; Verney E; Miale TD; Sidransky H
    Am J Pathol; 1967 Nov; 51(5):769-88. PubMed ID: 6054848
    [No Abstract]   [Full Text] [Related]  

  • 11. Histopathologic and antibody responses of rabbits exposed to aerosols containing spores of Aspergillus fumigatus: comparison of single and multiple exposures.
    Thurston JR; Peden WM; Driftmier KM; Richard JL
    Am J Vet Res; 1986 Apr; 47(4):919-23. PubMed ID: 3516034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
    Mehrad B; Strieter RM; Standiford TJ
    J Immunol; 1999 Feb; 162(3):1633-40. PubMed ID: 9973423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspergillosis].
    Maslin J; Morand JJ; Menard G; Camparo P
    Med Trop (Mars); 2004; 64(1):11-7. PubMed ID: 15224547
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.
    Cenci E; Mencacci A; Del Sero G; Bacci A; Montagnoli C; d'Ostiani CF; Mosci P; Bachmann M; Bistoni F; Kopf M; Romani L
    J Infect Dis; 1999 Dec; 180(6):1957-68. PubMed ID: 10558953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants.
    Shibuya K; Takaoka M; Uchida K; Wakayama M; Yamaguchi H; Takahashi K; Paris S; Latge JP; Naoe S
    Microb Pathog; 1999 Sep; 27(3):123-31. PubMed ID: 10455003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental aspergillosis in mice: aspects of resistance.
    Smith GR
    J Hyg (Lond); 1972 Dec; 70(4):741-54. PubMed ID: 4567315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of Aspergillus fungi to the development of bronchopulmonary pathology (literature review)].
    Kazarova TA
    Probl Tuberk; 1998; (1):57-61. PubMed ID: 9553444
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a vaccine for invasive aspergillosis.
    Sheppard DC; Edwards JE
    Clin Infect Dis; 2004 Apr; 38(8):1137-8. PubMed ID: 15095220
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
    Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
    J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.